Catalyst

Slingshot members are tracking this event:

Alder (ALDR) Announces Positive Results from Phase 1 Study Evaluating Quarterly Self-Administration of ALD403 in Chronic Migraine Patients

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ALDR

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 28, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Intravenous, Subcutaneous, Intramuscular, Phase 1 Study, Self Administration, Ald403